GENE ONLINE|News &
Opinion
Blog

M&A
M&A Cancer
Illumina Advances Talks to Acquire Healthcare Start-up Grail
2020-09-16
Oncology
Gilead Strengthens its Oncology Portfolio with Acquisition of Immunomedics
2020-09-14
Licensing Healthcare
Mylan Set to Expand Thrombosis Business in Europe with Aspen deal
2020-09-10
M&A Cardiovascular Disease
Encouraging Performance of Cardiovascular Drug Vindicates Novartis’ $9.7 Billion Buyout Deal
2020-09-06
M&A
Nestlé to Acquire Aimmune Therapeutics in a $2.6 Billion Merger Agreement
2020-09-01
M&A Peanut Allergy
Nestlé to Acquire Aimmune Therapeutics in a $2.6 Billion Merger Agreement
2020-08-31
Weekly Asia Highlights- Japan and India
2020-08-20
M&A Johnson & Johnson
Johnson & Johnson to Acquire Momenta Pharmaceutical Inc. for $6.5 Billion
2020-08-20
M&A Multiple Sclerosis
Sanofi Advances in Multiple Sclerosis Market with Principia Acquisition Deal
2020-08-18
M&A Healthcare
Teladoc Health, Livongo Join Hands for Global Healthcare Delivery, Access, and Experience
2020-08-09
Business Model and Financial Strategy DecisionsLicensing, M&A, partnering, scaling-up, IPO and m
2020-06-15Partner
M&A
Foundation Medicine Fortifies Growing Prominence in Liquid Biopsy Space by Acquiring Lexent Bio
2020-06-15
M&A Anti-inflammatory Drugs
AbbVie Completes Acquisition of Botox Manufacturer, Allergan
2020-05-11
M&A Molecular Diagnostics
Thermo Fisher Scientific to Acquire Qiagen in US$ 11.5 Billion Deal
2020-03-03
M&A CD47
Gilead Strikes US$ 4.9B Takeover Deal of Forty Seven
2020-03-02
1 … 11 12 13 14
LATEST
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top